Strive for innovative solutions in prevention, cure and care for the health and well being of people worldwide by combining our talents to understand and meet the needs of patients and their families for enhance their quality of life.
A human health care company capable of making a meaningful contribution under any health care system while observing the highest legal and ethical standards in business activities.
Eisai Co., Ltd. Japan is a multinational pharmaceutical company with strong R&D capabilities. It was founded in 1941, with the headquarters located in Tokyo. Since its foundation, the Company has actively expanded into overseas markets and now has sales subsidiaries and factories in America, Europe and Asia. As a research-based pharmaceutical company ,we give high priority to research and development activities. With Tsukuba Research Laboratories serving as a coordinating center, approximately 1300 researchers globally work around the clock to develop next-generation and innovative new drugs to satisfy unmet medical needs. Our research is focused on areas of expertise in neurology and gastrointestinal diseases, as well as oncology. We are also expanding research into new frontier areas in order to establish future specialty fields.
Eisai China Inc. is a pharmaceutical company solely invested by Eisai Co., Ltd. Japan, a multinational pharmaceutical company. Eisai has been developing smoothly in China since the early 1990s. It went through Shenyang Eisai and Eisai Suzhou successively (a Japan-funded company, located in Suzhou industrial Park), and later it was renamed as Eisai China Inc. since 2002.
Eisai China Inc., Suzhou Plant is located in Suzhou Industrial Park. The total investment amounts to USD 50 million. The total area of the company site is 25,000 square meters, of which the first-stage production building occupies 5,000 square meters, the second one 800 square meters, administration block 800 square meters and greenery 15,000 square meters. It was registered in March 1996, and the construction of the factory was finished in June 1998. It received GMP certification in the same years and production officially began in May 1999. The Suzhou Plant has begun a garbage-sorting program. The plant plans to continue its effects in order to become the "Green Eisai" in China.
Taking the hhc as corporation commitment, Compliance as business guide, and GMP as quality standard, Eisai China Inc. not only provides high-quality, environment-friendly, safe and satisfied products and services to patients and their families, but also actively repay the society by sponsoring medical institutes and establishing scholarships and etc. We will make unceasing efforts in contributing to development of China's pharmacy market. At present, Neurology, Digestive diseases and cardiovascular disease are major areas on which our products focused.
Eisai China Inc. is developing very rapidly. We are hoping that you can help us make more and more successes as a member of OUR WINNING TEAM. We believe that you will find the job will not only match your abilities and passion but also be a great career opportunity. Hope to see you soon!